Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 71,587 | 51,379 | 40,141 | 20,924 | 81,923 |
| Depreciation Amortization | 41,213 | 29,507 | 18,054 | 6,555 | 21,387 |
| Income taxes - deferred | -5,694 | -247 | -798 | 1,803 | -4,097 |
| Other Working Capital | -253,279 | -71,755 | -103,190 | -85,367 | -80,945 |
| Other Operating Activity | 24,916 | 23,245 | 21,681 | 19,706 | 4,455 |
| Operating Cash Flow | $-121,257 | $32,129 | $-24,112 | $-36,379 | $22,723 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,497 | -1,137 | -533 | -319 | -2,754 |
| Net Acquisitions | 29,050 | 41,690 | 66,490 | 52,473 | -189,269 |
| Other Investing Activity | -2,000 | -2,000 | -2,000 | -2,000 | 0 |
| Investing Cash Flow | $23,553 | $38,553 | $63,957 | $50,154 | $-192,023 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 245,693 |
| Debt Repayment | -7,700 | -6,300 | N/A | N/A | -10,573 |
| Common Stock Issued | 9,892 | 9,613 | 9,409 | 8,556 | 328 |
| Dividend Paid | -2,367 | -2,367 | N/A | N/A | N/A |
| Financing Cash Flow | $-175 | $946 | $9,409 | $8,556 | $235,448 |
| Beginning Cash Position | 149,922 | 152,220 | 152,220 | 152,220 | 83,774 |
| End Cash Position | 52,043 | 223,848 | 201,474 | 174,551 | 149,922 |
| Net Cash Flow | $-97,879 | $71,628 | $49,254 | $22,331 | $66,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,257 | 32,129 | -24,112 | -36,379 | 22,723 |
| Capital Expenditure | -3,497 | -1,137 | -533 | -319 | -2,754 |
| Free Cash Flow | -124,754 | 30,992 | -24,645 | -36,698 | 19,969 |